ARCHIVES

Ivax Paclitaxel To Remain On Market In Deal With BMS.

This article is from The Cancer Letter archive.

Vol. 28 No. 05 | February 1, 2002

Download PDF Visit The Full Archive

Related Articles

New Research Training Act May Permit NCI To Help fill Clinical Gaps In Radiotherapy, Medical Oncology

July 26, 1974

Advisors Voted For Provenge Approval Despite Fundamental Flaws In Trials.

April 13, 2007

SWOG Five Drug Adjuvant Breast Study Shows Remarkable Survival For Older, Younger Women

March 30, 1979

Patients on Hypertension Meds Lived Longer, Analysis Shows

January 31, 2014

Also MSKCC picks David Kissane to succeed Jimmie Holland as chairman of psychiatry and behavioral sciences.

October 24, 2003

Wider Use Of Adjuvant Chemotherapy Recommended By NIH Consensus Panel.

November 10, 2000